Publication | Closed Access

Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor α levels

Single AgentMedicineHematologyRefractory AnemiaPharmacotherapyClinical ChemistryPharmacologyClinical OutcomeAplastic AnemiaAnesthesiology